Incremental net benefit of lipid-lowering therapy with PCSK9 inhibitors: a systematic review and meta-analysis of cost-utility studies
Bhavani Shankara Bagepally, Akhil Sasidharan
Topics & Concepts
MedicineMeta-analysisConfidence intervalChecklistCost effectivenessEvolocumabCost-effectiveness analysisPopulationInternal medicineIncremental cost-effectiveness ratioCholesterolEnvironmental healthPsychologyCognitive psychologyRisk analysis (engineering)Apolipoprotein BApolipoprotein A1Lipoproteins and Cardiovascular HealthPharmaceutical Practices and Patient OutcomesMedication Adherence and Compliance